The vast reach of USAID’s NTD Program and the NTD treatments delivered have been made possible due to generous commitments from the pharmaceutical sector. Six of the drugs needed to eliminate and control NTDs are donated by the pharmaceutical companies Eisai, GlaxoSmithKline, Merck & Co., Merck KGaA, Johnson & Johnson and Pfizer. The USAID NTD Program works with countries to forecast and efficiently distribute these donated drugs to target audiences.

Since USAID’s NTD Program began distributing donated drugs in 2007, the drug donation programs have expanded significantly. The NTD drugs donated to the USAID-supported countries have been valued at over $26.1 billion, representing the largest public-private partnership in the Agency, with a leverage of $26 in donated drugs for every tax dollar spent by USAID.

Six of the drugs needed to treat NTDs are donated by:

Eisai logo GSK logo Johnson and Johnson logo Merk Logo EMD Serono Pfizer logo

Value of Drugs Donated
Created with Highcharts 4.2.6Value (in millions of US $)Value of Drugs Donated to USAID Supported CountriesSource:NTD Program data collection system via ENVISION2006200720082009201020112012201320142015201620172018201901k2k3k4k5k
2019
Yearly Drug Value: $3781.0 million